Over the past 4 years in Cleveland, Ohio there have been 34 cases of pulmonary hemorrhage and hemosiderosis in young infants. To date, ten infants have died. A CDC case-controlled study found an association with water damaged homes and the toxigenic fungus called Stachybotrys atra which requires water-saturated cellulose to grow. The spores of this fungus do not germinate in the lung, but do not contain very potent mycotoxins which appear to be particularly toxic to the rapidly developing lungs of young infants. Secondary stresses, e.g. environmental tobacco smoke, appear to be important triggers for overt hemorrhage. Concern that there may be a large number of undetected infants with the disorder ted to examination of all infant coroner cases, which revealed six sudden infant death syndrome cases with major amounts of pulmonary hemosiderin-laden macrophages, indicating extensive hemosiderosis existing prior to death. All of these infants lived in the same contiguous area as the majority of the hemosiderosis patients. This disorder may extend beyond Cleveland, since toxigenic fungi are widespread. We are aware of 122 infants with idiopathic pulmonary hemorrhage in this country in the past 4 years. The purpose of this proposal is to establish an original rat pup model for Stachybotrymycotoxicosis which can be used to understand the developmental pathophysiology by which fungal spores induces hemorrhage, address practical problems in clinical care, and foster public health prevention. This model uses tracheal instillation of toxic Stachybotrys spores in neonatal to weanling rats to initiate the pathologic process.
Specific aim 1 will evaluate dose response to Stachybotrys spore inhalation, critical age of vulnerability, histopathology, inflammatory mediator response, and change in lung function during injury and recovery.
Specific aim 2 will explore the vulnerability of pulmonary capillaries to leakage in the Stachybotrys exposed pups in vivo and in vitro, specific stress triggers of hemorrhage, and efficacy of anti- inflammatory therapy.
Specific aim 3 will develop and test biochemical markers for Stachybotrys exposure including toxins and antibody production. The experiments in this proposal will provide fundamental new information on Stachybotrys exposure applicable to detection and treatment of this new disorder.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES009742-05
Application #
6628624
Study Section
Lung Biology and Pathology Study Section (LBPA)
Program Officer
Tinkle, Sally S
Project Start
1999-02-05
Project End
2005-01-31
Budget Start
2003-02-01
Budget End
2005-01-31
Support Year
5
Fiscal Year
2003
Total Cost
$350,105
Indirect Cost
Name
Case Western Reserve University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Pestka, James J; Yike, Iwona; Dearborn, Dorr G et al. (2008) Stachybotrys chartarum, trichothecene mycotoxins, and damp building-related illness: new insights into a public health enigma. Toxicol Sci 104:4-26
Yike, Iwona; Rand, Thomas; Dearborn, Dorr G (2007) The role of fungal proteinases in pathophysiology of Stachybotrys chartarum. Mycopathologia 164:171-81
Yike, Iwona; Rand, Thomas G; Dearborn, Dorr G (2005) Acute inflammatory responses to Stachybotrys chartarum in the lungs of infant rats: time course and possible mechanisms. Toxicol Sci 84:408-17
Yike, Iwona; Vesper, Stephen; Tomashefski Jr, Joseph F et al. (2003) Germination, viability and clearance of Stachybotrys chartarum in the lungs of infant rats. Mycopathologia 156:67-75
Yike, Iwona; Miller, Martha J; Sorenson, W G et al. (2002) Infant animal model of pulmonary mycotoxicosis induced by Stachybotrys chartarum. Mycopathologia 154:139-52
Dearborn, Dorr G; Smith, Paul G; Dahms, Beverly B et al. (2002) Clinical profile of 30 infants with acute pulmonary hemorrhage in Cleveland. Pediatrics 110:627-37